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Abstract
Background Implicit negative attitudes towards other races
are important in certain kinds of prejudicial social behaviour.
Emotional mechanisms are thought to be involved in mediating
implicit “outgroup” bias but there is little evidence concerning
the underlying neurobiology. The aim of the present study was
to examine the role of noradrenergic mechanisms in the
generation of implicit racial attitudes.
Methods Healthy volunteers (n036) of white ethnic origin,
received a single oral dose of the β-adrenoceptor antagonist,
propranolol (40 mg), in a randomised, double-blind, parallel
group, placebo-controlled, design. Participants completed an
explicit measure of prejudice and the racial implicit association
test (IAT), 1–2 h after propranolol administration.
Results Relative to placebo, propranolol significantly lowered
heart rate and abolished implicit racial bias, without affecting
the measure of explicit racial prejudice. Propranolol did not
affect subjective mood.
Conclusions Our results indicate that β-adrenoceptors play
a role in the expression of implicit racial attitudes suggesting
that noradrenaline-related emotional mechanisms may
mediate negative racial bias. Our findings may also have
practical importance given that propranolol is a widely used
drug. However, further studies will be needed to examine
whether a similar effect can be demonstrated in the course of
clinical treatment.
Keywords Noradrenaline . Propranolol . Implicit racial
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Introduction
Negative evaluations of minority groups are a central source
of avoidance, discrimination, and conflict — problems
which are of particular importance in today’s increasingly
cosmopolitan world. The dominance of political norms of
equality and tolerance in Western democracies limits the
overt expression of prejudice in such countries (Schuman
et al. 1997). There is, however, extensive evidence that
implicit bias — automatic negative attitudes associated with
out-group members (Greenwald et al. 1998) — remains a
live and a potent influence.
The implicit association test (IAT) (Greenwald et al. 2009)
is a widely used method to assess implicit attitudes to which
individuals may have limited introspective access (Nosek
et al. 2007). In this item-sorting task, latency differences
between prejudice congruent and incongruent trials are
evaluated, to measure implicit bias. There is now extensive
evidence that the IAT is a reliable measure of implicit attitudes
towards social outgroups, whether based on race, sexual
orientation, gender, or political preference (Nosek et al.
2007). IATs were developed precisely to reduce the effect of
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social desirability responses which might affect explicit prej-
udice responses (Greenwald et al. 1998). A recent meta-
analysis further suggests that the IAT is a consistently better
predictor of discrimination against out-group members than
measures of explicit prejudice (Poehlman et al. 2004). It has
been suggested, however, that implicit measures best predict
subtle and spontaneous biased behaviour (Nosek et al. 2007),
whereas explicit prejudice measures predict deliberate behav-
iour (Fazio et al. 1995).
Several studies have suggested that, compared to explicit
prejudice, implicit prejudice involves a stronger emotional
component. For example, Phelps et al (2000) found
increased amygdala activity when white participants viewed
faces of unknown black people, a finding confirmed by
other studies (Amodio 2003; Lieberman et al. 2005; Wheeler
and Fiske 2005). Importantly, the magnitude of amygdala
activation was correlated with the participants’ IAT score.
However, these previous studies are largely correlational in
nature, and cannot establish the causal mechanisms that
underlie implicit bias.
Pharmacological interventions offer another way to study
the causal role of emotional processes in implicit bias, and
noradrenaline pathways involving β-adrenergic receptors
are known to play a role in emotional memory and emo-
tional perception (Cahill et al. 1994; Harmer et al. 2001) as
judged by the effects of the non-selective β-adrenoceptor
antagonist, propranolol. Besides its well-established effect
on emotional memory via reduction in emotional condition-
ing (Chamberlaine et al. 2006), functional neuroimaging
studies have also shown that propranolol leads to a reduc-
tion in amygdala responses to both facial expressions and
visual emotional stimuli (Hurlemann et al. 2010a, b; van
Stegeren et al. 2005).
In the present study, therefore we employed propran-
olol to test the hypothesis that emotional responses
influenced by noradrenergic transmission play a mediat-
ing role in implicit but not in explicit forms of preju-
dice. We predicted that β-adrenoceptor blockade should
lead to a reduction in implicit racial attitudes, as mea-
sured by the IAT, without a corresponding reduction in
measures of explicit prejudice.
Methods and materials
Participants
We studied 36 healthy volunteers who gave full informed,
written consent to the study. Participants were all of white
ethnic origin, mostly from a British student population.
They were screened by a trained clinician to be free of any
Axis 1 Psychiatric Disorder using the Structured Clinical
Interview for DSM-IV (SCID-IV); they also underwent a
brief medical examination which included an ECG and
blood pressure measurement to exclude those suffering
any medical contraindication to propranolol administration
(epilepsy, asthma, heart disease). Participants then completed
the Beck Depression Inventory (BDI) (Beck et al. 1961) and
the Eysenck Neuroticism Scale (Eysenck and Eysenck 1964).
Ethical approval was obtained from the local NHS research
ethics committee. Participants received £30 and travel
expenses in compensation.
Procedure
Eligible participants were invited for a second visit to take
part in the experiment. They were asked to refrain from
alcohol and coffee on the study day. Participants were
randomly allocated to take either propranolol (40 mg orally)
or placebo in identical capsules in a parallel group, double-
blind design. Pulse rate was monitored at 30-min intervals
starting before drug administration and continuing until the
end of the study. After drug treatment participants rested for
1 h after which the measure of explicit prejudice measure
was administered 70 min and the IAT at 120 min after drug
treatment; this timing was based on the pharmacokinetics of
propranolol with peak plasma concentrations being reached
between 1 and 2 h (Gilman 1996). Subjective mood was
assessed using a Visual Analogue Scale (VAS), which asked
participants to rate themselves on six emotions (tense, angry,
happy, sad, tired, alert) on continuous scales (0–10 anchors).
Participants were instructed to report their “feeling at this
moment”. Participants completed the VAS scales at three
time points: before, 1 h and 3 h after propranolol/placebo
administration.
Tasks
Explicit prejudice measure
A feeling thermometer, an established tool for measuring
explicit prejudice (Converse and Presser 1986), was used;
on a 10-point scale, ranging from 0° to 100° (split into ten
categories) — analogous to a thermometer — participants
rated how “warm” they felt towards various groups. Besides
white and black people, they also indicated their attitude
towards homosexuals, Muslims, Christians, and drug
addicts. Differences between the scales for in- versus out-
group ratings indicate the level of explicit prejudice.
Implicit association test
A computerised racial picture version of the IAT was used,
administrated using e-prime software. The design of the task
followed that of the original version used by Greenwald
et al. (1998).
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The tasks consisted of seven blocks, each with 20 trials.
Participants were asked to respond as quickly and accurately as
possible. Participants were asked to perform a categorisation
task by sorting positive/negative words and pictures of faces of
black/white individuals. Target words appeared in the centre of
the screen, categories on the left/right corner. To assign items to
the left category participants pressed the “e” key, for the right
category they pressed the “i” key. Blocks 1 and 5 contained
positive/negative words, block 2 black/white faces, blocks 3, 4,
6, and 7 combinations in randomised order (see also Table S1).
The IAT effect was determined by latency differences in
the time to respond in the main trials: blocks 7 and 4 (e.g.,
prejudice congruent vs. prejudice incongruent blocks) as
well as in the practice trials (blocks 3 and 6). The pictures
of black and white faces, as well as positive and negative
words, were taken from the original test.
Statistics
The IAT was analysed according to the improved algorithm
as provided by Greenwald et al. (2003). In this method, the
main trials (Blocks 4, 7) as well as the practice trials (Blocks
3, 6) are analysed. First, error latencies were replaced by the
mean response time for correct trials +600 ms. Only data
from blocks with less than 15% errors were analysed (one
participant was excluded due to more than 20% errors on
practice and main trials, for three other participants only the
main trials were analysed due to too many errors in the
practice trials). The two differences — between blocks 7
and 4, and 6 and 3 — were divided by the pooled standard
deviation for correct trials. The average of the corrected
differences revealed the IAT effect.
The IAT, heart rate and VAS ratings were analysed using
analysis of variance (ANOVA). For VAS and heart rate
measures, there was one main between subject factor “treat-
ment” (propranolol vs. placebo) and one within subject
factor, “time”. For the IAT the main between subject factor
was also “Time” while the within-subject factor was “con-
gruency” (congruent vs. incongruent) stimuli. Significant
interactions on the ANOVA were followed up with post-
hoc unpaired t-tests (two-tailed). Scores on the explicit
racial prejudice measure were analysed by subtracting the
attitude score for white people from that for black people
(the same procedure was used for the assessment of other
explicit prejudices). Group differences were assessed with
the Mann–Whitney U-test. Demographic data were analysed
with unpaired t-tests (two-tailed).
Results
We studied 36 participants, 18 of whom received propranolol
and 18 placebo. The groups were well matched in terms of
demographic measures as well as measures of mood (Table 1).
Relative to placebo, propranolol did not alter VAS ratings of
any of the six emotions (no main or interaction effects on
ANOVA, all p>0.2).
Propranolol significantly lowered heart rate (calculated as
change from baseline) as shown by a significant main effect
of treatment on the ANOVA (F(4, 30) 0 6.56, p00.02), as
well as a time × treatment (F(4, 30) 0 4.62, p00.00). Post hoc
t-tests revealed that the heart rate change (e.g., the drop of
the pulse from baseline) was significantly greater in the
propranolol group (at 60 min: M0−8.17, SD06.76; at
90 min: M0−7.27, SD07.16; at 120 min: M0−8.55,
SD07.77) as compared to the placebo group (at 60 min:
M0−3.18, SD04.74; at 90 min: M0−.722, SD07.16; at
120 min: M0−1.67, SD09.19) (at 60 min: t(33) 0 2.51,
p00.02; d0−0.87; at 90 min: t(34) 0 2.4, p00.02; d00.78; at
120 min: t(34) 0 2.4, p00.02; d00.8).
We found no effect of propranolol on the measure of
explicit prejudice as judged using the Mann–Whitney U-test
for independent, non-parametric data. Additionally, no sig-
nificant difference between the propranolol and placebo
groups was found for religious prejudice, sexual prejudice,
or prejudice against drug addicted individuals (all p>0.2),
see Table 2.
The measure of the IAT reaction times showed the
expected main effect of congruency (F(1, 33) 0 13.60,
p00.001) (i.e., the IAT effect), as well as a significant
congruency × treatment interaction (F(1, 33) 0 6.20,
p00.02). There was no main effect of treatment
(F(1, 33) 0 0.26, p00.61). Post hoc t-tests revealed no sig-
nificant difference between groups in mean response times
(ms) on congruent (placebo: M0702.98, SD086.67; pro-
pranolol: M0788.72, SD0175.07) or incongruent (placebo:
M 0866.23, SD 0168.98; propranolol: M 0820.50,
SD0106.68) trials (t(33) 0 −1.85, p>0.05; t(33) 0 0.95,
p>0.05). However, an unpaired t-test showed the difference
between congruent and incongruent trials (the IAT effect)
was significantly smaller in the propranolol (M00.26,
SD01.09) as compared to the placebo group (M01.02,
SD00.84) (t(33) 0 2.3, p00.03; d00.8) (see Fig. 1). Paired
t-tests also revealed that an IAT effect (a significant differ-
ence between the congruent and incongruent trials) could be
determined for both practice (M0112.13, SD0111.06) and
main (M0161.05, SD0244.53) trials in the placebo group
(t(17) 0 4.30, p00.001; t(17) 0 2.80, p00.01), but not in the
propranolol group (M0−26.30, SD0198.08; M065.55,
SD0153.10; t(18) 0 −0.53, p>0.05; t(18)01.82, p>0.05).
Additionally, in the propranolol group 34% of the
participants had a “negative” IAT score (they were faster
in the “bias”-incongruent as compared to the congruent
condition). In the placebo group no subject had such a
score. This difference was significant (χ2(1, n037) 0 7.2,
p00.02).
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Discussion
The main finding of our study is that propranolol signifi-
cantly reduced implicit but not explicit racial bias. This
supports our hypothesis that noradrenaline-mediated emo-
tional responses play a role in the generation of implicit
negative racial attitudes, and supports prior theorising sug-
gesting a greater affective component in implicit attitudes
(Stanley et al. 2008).
Propranolol in single doses is a well-established
means of assessing the role of noradrenaline pathways
in emotional learning and perception (Cahill et al. 1994;
Harmer et al. 2001; Hurlemann et al. 2010a, b; Mihov
et al. 2010). However, β-adrenoceptor antagonists have
other neuropsychological effects which need to be con-
sidered in our findings. Our subjective ratings do not
suggest that propranolol caused sedation relative to
placebo. In addition, it seems unlikely that the observed
effect on IAT was due to a general impairing effect of
propranolol on cognitive performance, given that previous
research has demonstrated that propranolol and other beta
blockers do not impair performance on purely cognitive
conflict tasks, such as the standard Stroop test (Harvey et al.
1977; Lasser et al. 1989; Nakano et al. 1978). In addition,
propranolol did not cause an overall slowing of reaction time
in the IAT task.
Further research is needed to clarify the causal mecha-
nisms through which noradrenergic pathways may influence
implicit bias. Although our study used only behavioural
measures, prior studies have shown that propranolol can
reduce amygdala response to visual stimuli associated with
negative emotions such as fear and anger (Van Stegeren
et al. 2005), and the role of noradrenergic transmission in
the basolateral amygdala in emotional processing has also
been demonstrated in animal studies (McGaugh 2000). The
amygdala plays a key role in the early non-conscious
appraisal of threat, and may therefore also be involved in
the mediation of implicit racial prejudice. In line with this
proposal, previous neuroimaging studies found that
increased amygdala activation was associated with implicit
prejudice but not with explicit racial attitudes (Phelps et al.
2000). However, Phelps et al (2003) found that a single
patient with bilateral amygdala damage exhibited an intact
IAT effect, leading the authors to suggest that the amygdala
may not be a critical structure for the manifestation of
implicit bias.
Phelps et al (2003) proposed instead that the amygdala
may be involved in the acquisition of emotional bias, or that
common neural pathways influence both behaviour on the
IAT and responses in the amygdala to the task. It is also
possible that in presence of amygdala damage, other com-
pensatory mechanisms may be recruited in the IAT task. It
Table 1 Demographic data for
propranolol and placebo group
BDI Beck Depression Inventory,
n.s. not significant
Non-significant differences: all
p>0.2
Group Propanolol Placebo
Age M022.33 M022.72 n.s.
SD03.94 SD03.08
Gender Male: n09 Male: n010 n.s.
Female: n09 Female: n08
Ethnic Origin White British: n08 White British: n010 n.s.
Other white European: n06 Other white European: n05
White American: n03 White American: n03
Depressed Mood (BDI) M02.06 M02.82 n.s.
SD01.78 SD02.43
Neuroticism (Eysenck) M04.88 M05.18 n.s.
SD03.64 SD02.98
Table 2 Explicit Prejudice
measure for propranolol and
placebo group
Non-significant results: p>0.2
Group Propanolol Placebo
Explicit racial prejudice score Mean rank 0 18.22 Mean rank 0 18.78 Z0−0.201
n.s.
Explicit religious prejudice score Mean rank 0 19.17 Mean rank 0 17.83 Z0−0.399
n.s.
Explicit sexual prejudice score Mean rank 0 18.81 Mean rank 0 18.19 Z0−0.195
n.s.
Explicit Prejudice score: drug
addicted individuals
Mean rank 0 16.58 Mean rank 0 20.42 Z0−0.1180
n.s
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thus remains possible that automatic fear or threat responses
related to amygdala activation and normally elicited by
viewing of out-group faces might be the central emotional
component mediating implicit attitudes. Propranolol might
act at this level to produce its effect on the IAT, although
further neuroimaging studies are needed to confirm reduction
in limbic activation in response to such social cues following
propranolol.
Another possibility is that the observed effect of propran-
olol on implicit attitudes is due to a decrease in peripheral
sympathetic responses. It could be, for example, that negative
implicit attitudes are triggered by somatic experiences depen-
dent on increased sympathetic activation independent of
amygdala activation. Propranolol may lead to a significant
reduction in such response, and thereby reduce the “embod-
ied” experience of emotional responses to a racial out-group.
Further studies with a peripherally acting β-adrenoceptor
antagonist, such as nadolol, are needed to determine whether
the action of propranolol observed here is mediated by
peripheral or central mechanisms. For example, Van Stegeren
et al (1998) found that memory for emotional stimuli was
impaired by propranolol but not nadolol, suggesting a central
location for the relevant β-adrenoceptors.
The influence of propranolol on implicit attitudes observed
in the present study may shed new light on the neurobiological
mechanisms underlying implicit prejudice. Given the impor-
tant role that implicit attitudes appear to play in overt forms of
discrimination against out-group members, and the wide-
spread use of propranolol for medical purposes, our findings
might also be of practical interest, and require careful ethical
consideration. Further research, however, is needed to clarify
whether the observed effect would persist with sustained
propranolol treatment, and whether propranolol can modulate
implicit bias outside the laboratory.
It should be noted that our measures of explicit and implicit
prejudice were given in a fixed order with a time gap between
the two in order to try to avoid the tests influencing each other
(e.g., to reduce awareness that “prejudice” was tested). This
might have produced a confounding effect whereby previous
explicit testing of prejudice interacted with propranolol to
affect the IAT. It is also possible that the effect of propranolol
to block β-adrenoceptors might have been more pronounced
at the time of IAT testing. Against this latter possibility,
however, was our finding that the physiological effect of
propranolol (a significant drop in heart rate) was present and
similar throughout the relevant testing period (60–120 min).
This is in accordance with the peak plasma concentration for
propranolol (Gilman 1996).
Recently, De Dreu et al (2011) reported that in-group
favouritism was increased by oxytocin, a peptide hormone
that has been implicated in trust, cooperation, and positive
emotions. In one of their tasks, De Dreu et al (2011) used the
IAT to measure the responses of Dutch participants to Arab
or German minorities. The authors found, by comparing
response times of positive associations made to in-group
versus out-group members, that oxytocin increased response
latency differences for positive associations, indicating an
increase in in-group favouritism. This is of interest in the
light of our findings because there are interactions between
oxytocin and noradrenaline pathways, and in animals pro-
pranolol can lower oxytocin levels. Furthermore, Hurlemann
et al. (2010a, b) have suggested that the ability of oxytocin to
facilitate socially reinforced learning is mediated via
beta-adrenergic mechanisms in the amygdala. Further
studies in humans are required to test this interesting
proposal.
It is also possible that the effect of propranolol to de-
crease racial prejudice is mediated through a more general
reduction in out-group denigration, in-group favouritism or
both. Further studies could investigate these evaluative asso-
ciations using, for example, the Go/No-go Association Task
(GNAT; Nosek and Banaji 2001).
To conclude, the influence of propranolol on implicit
attitudes observed in the present study may shed new light
on the neurobiological mechanisms underlying implicit
prejudice. Given the important role that implicit attitudes
Fig. 1 Mean response times in
the IAT for both groups
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appear to play in overt forms of discrimination against out-
group members, and the widespread use of propranolol for
medical purposes, our findings might also be of practical
interest, and require careful ethical consideration. Further
research, however, is needed to clarify whether the observed
effect would persist with sustained propranolol treatment,
and whether propranolol can modulate implicit bias outside
the laboratory.
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